PCR Firm QuantaLife Raises $17.2M in Series B

The company will use the funds to commercialize its Droplet Digital PCR platform launched last month and accelerate development of targeted diagnostic tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories